About: Long-term use of yeast fermentation products in comparison to halofuginone for the control of cryptosporidiosis in neonatal calves

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Long-term use of yeast fermentation products in comparison to halofuginone for the control of cryptosporidiosis in neonatal calves Goto Sponge NotDistinct Permalink

An Entity of Type : schema:ScholarlyArticle, within Data Space : covidontheweb.inria.fr associated with source document(s)

Attributes	Values
type	Academic Article research paper schema:ScholarlyArticle
isDefinedBy	Covid-on-the-Web dataset
title	Long-term use of yeast fermentation products in comparison to halofuginone for the control of cryptosporidiosis in neonatal calves
Creator	Failing, Klaus Bauer, Christian Vélez, Juan Yoon, Ilkyu Zieger, Peter Lange, Malin
source	Elsevier; Medline; PMC
abstract	Abstract The objective of this study was to compare the effect of non-GMO Saccharomyces cerevisiae fermentation products (SCFP) with that of a halofuginone treatment against Cryptosporidium parvum infection in pre-weaned calves on a commercial dairy farm. A total of 123 neonatal female calves, housed in individual hutches, were enrolled sequentially based on date of birth in 41 blocks of 3 animals each. Calves within each block were allocated to one of 3 treatments: remaining untreated, fed with SCFP (Diamond V SmartCare® at 1 g/d in milk and NutriTek® at 5 g/d in starter grain) for the first 63 days of life, or treated with halofuginone (0.1 mg/kg/d) for the first 7 days of life. Fecal samples collected on days 4–21 post-partum were examined for both Cryptosporidium oocysts and coproantigen. The presence and intensity of diarrhea were monitored by scoring daily for the first 4 weeks of life. Calves were weighed at 0, 21, 42 and 63 days of age. Almost all calves were Cryptosporidium-positive at least once during the study. Halofuginone significantly reduced the number of Cryptosporidium-positive fecal samples as compared to the two other groups. Based on the coproantigen scores, both halofuginone and SCFP feeding significantly reduced the intensity of Cryptosporidium infection as compared to the untreated group. Diarrhea was recorded in almost all calves at least once. Neither the proportion of diarrheic calves nor the intensity and duration of diarrhea differed among the 3 treatment groups significantly. The mean daily weight gain during the first 3 weeks of life was significantly lower in halofuginone treated calves than in both other groups; however, at the end of the study period the total weight gain did not significantly differ among the 3 treatment groups. In conclusion, the clinical results and weight gains of pre-weaning supplementation with the SCFP were neither better nor worse than the 7-day halofuginone treatment suggesting that the SCFP feeding may be from the clinical point of view a natural alternative measure, instead of halofuginone treatment, in bovine cryptosporidiosis.
has issue date	2019-05-31(xsd:dateTime)
bibo:doi	10.1016/j.vetpar.2019.04.008
bibo:pmid	31079829
has license	els-covid
sha1sum (hex)	9cbda17d77d5e6990cd7da048727a59f579e9261
schema:url	https://doi.org/10.1016/j.vetpar.2019.04.008
resource representing a document's title	Long-term use of yeast fermentation products in comparison to halofuginone for the control of cryptosporidiosis in neonatal calves
has PubMed Central identifier	PMC7117046
has PubMed identifier	31079829
schema:publication	Veterinary Parasitology
resource representing a document's body	covid:9cbda17d77d5e6990cd7da048727a59f579e9261#body_text
is schema:about of	named entity 'CALVES' named entity 'weight gain' named entity 'milk' named entity 'compared' named entity 'oocysts' named entity 'neonatal' named entity 'USE OF' named entity 'YEAST' named entity 'HALOFUGINONE' named entity 'COMPARISON' named entity 'NEITHER' named entity 'POSITIVE' named entity 'FERMENTATION' named entity 'ALMOST ALL' named entity 'TREATED WITH' named entity 'WORSE' named entity 'UNTREATED' named entity 'BETTER' named entity 'AGE' named entity 'RECORDED' named entity 'LOWER' named entity 'CLINICAL RESULTS' named entity 'ONE OF' named entity 'SACCHAROMYCES CEREVISIAE' named entity 'SUPPLEMENTATION' named entity 'DURATION OF DIARRHEA' named entity 'GMO' named entity 'NON-' named entity 'BOVINE' named entity 'NUMBER OF' named entity 'CRYPTOSPORIDIUM' named entity 'GROUPS' named entity 'TREATED' named entity 'PARTUM' named entity 'CONCLUSION' named entity 'DATE OF BIRTH' named entity 'CRYPTOSPORIDIOSIS' named entity 'PRESENCE' named entity 'INTENSITY' named entity 'WEANING' named entity 'NATURAL' named entity 'ALTERNATIVE' named entity 'INFECTION' named entity 'NEONATAL' named entity 'COLLECTED' named entity 'MG%' named entity 'CONTROL' named entity 'CRYPTOSPORIDIOSIS' named entity 'LONG-TERM' named entity 'GROUP' named entity 'SCORES' named entity 'CLINICAL' named entity 'DIARRHEA' named entity 'REMAINING' named entity 'FEMALE' named entity 'FERMENTATION' named entity 'PRODUCTS' named entity 'POST' named entity '4 WEEKS' named entity 'SCORING' named entity 'DID' named entity 'TREATMENT' named entity 'PROPORTION' named entity 'MEAN' named entity 'STUDY' named entity 'BLOCKS' named entity 'MILK' named entity 'TREATMENTS' named entity 'POINT OF VIEW' named entity 'INDIVIDUAL' named entity 'OBJECTIVE' named entity 'CRYPTOSPORIDIUM PARVUM' named entity 'CALVES' named entity 'PRE' named entity '3 WEEKS' named entity 'FEEDING'

Faceted Search & Find service v1.13.91 as of Mar 24 2020

Alternative Linked Data Documents: Sponger | ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3229 as of Jul 10 2020, on Linux (x86_64-pc-linux-gnu), Single-Server Edition (94 GB total memory)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2025 OpenLink Software